Evidence map›Paper›PMID 17565177›Full record

ArticleActa crystallographica. Section F, Structural biology and crystallization communications2007

Humidity control as a strategy for lattice optimization applied to crystals of HLA-A*1101 complexed with variant peptides from dengue virus.

Pojchong Chotiyarnwong, Guillaume B Stewart-Jones, Michael J Tarry, Wanwisa Dejnirattisai, Christian Siebold, Michael Koch, David I Stuart, Karl Harlos, Prida Malasit, Gavin Screaton and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Acta crystallographica. Section F, Structural biology and crystallization communications, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. IR laser-induced protein crystal transformation.Acta crystallographica. Section D, Biological crystallography · 2014
    Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Pojchong ChotiyarnwongDepartment of Immunology, Division of Medicine, Hammersmith Hospital, Imperial College, London, England.
Guillaume B Stewart-Jones
Michael J Tarry
Wanwisa Dejnirattisai
Christian Siebold
Michael Koch
David I Stuart
Karl Harlos
Prida Malasit
Gavin Screaton
Juthathip Mongkolsapaya
E Yvonne Jones
Centre for Human Genetics · GBSiriraj Hospital · THImperial College London · GBMahidol University · THNational Science and Technology Development Agency · TH

Funding

Medical Research Council G0500365Medical Research Council G9900061Medical Research Council MC_U137884178Wellcome Trust
6 · The paper itself

Abstract

T-cell recognition of the antigenic peptides presented by MHC class I molecules normally triggers protective immune responses, but can result in immune enhancement of disease. Cross-reactive T-cell responses may underlie immunopathology in dengue haemorrhagic fever. To analyze these effects at the molecular level, the functional MHC class I molecule HLA-A*1101 was crystallized bound to six naturally occurring peptide variants from the dengue virus NS3 protein. The crystals contained high levels of solvent and required optimization of the cryoprotectant and dehydration protocols for each complex to yield well ordered diffraction, a process that was facilitated by the use of a free-mounting system.

Indexed as

HumidityAmino Acid SequenceChromatography, GelCrystallizationCrystallography, X-RayDengue VirusHLA-A AntigensPeptidesProtein ConformationViral ProteinsHLA-A AntigensPeptidesViral Proteins

Identifiers

PMID17565177
PMCPMC2334998
OpenAlexW2025503429

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.